STOCK TITAN

[4] – LUCIER GREGORY T (CIK 0001251299)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

DENTSPLY SIRONA (XRAY): Form 4 insider transaction by a director. On 10/10/2025, 310.397 shares of common stock were acquired at $0 as dividends on restricted stock units credited to a Family Partnership. Following this, beneficial holdings were 24,357.397 shares indirect by Family Partnership, 82,301.434 shares direct, and 21,000 shares indirect by a Gregory Lucier IRA.

On 10/14/2025, the reporting person made a gift (Code G) of 17,200 non‑qualified stock options with a $12.96 exercise price to a Family Partnership. These options are exercisable beginning 08/08/2026 and expire on 08/08/2035. The filing notes the gift and includes a standard disclaimer of beneficial ownership except to the extent of pecuniary interest.

DENTSPLY SIRONA (XRAY): Transazione interna di livello 4 da parte di un direttore. Il 10/10/2025 sono state acquisite 310.397 azioni ordinarie a 0$ come dividendi su unità azionarie limitate accreditate a una Family Partnership. A seguito di ciò, le partecipazioni benefici erano 24.357.397 azioni indirette tramite Family Partnership, 82.301.434 azioni dirette e 21.000 azioni indirette da un Individual Retirement Account di Gregory Lucier.

Il 14/10/2025, la persona riferente ha effettuato un dono (Codice G) di 17.200 stock options non qualificate con un prezzo di esercizio di 12,96$ a una Family Partnership. Queste opzioni possono essere esercitate dall'08/08/2026 e scadono l'08/08/2035. La comunicazione riporta il dono e include una normale esclusione della proprietà beneficiaria salvo l'interesse pecuniario.

DENTSPLY SIRONA (XRAY): Transacción de nivel 4 por parte de un director. El 10/10/2025, se adquirieron 310.397 acciones comunes a $0 como dividendos en unidades de acciones restringidas acreditadas a una Family Partnership. Tras esto, las participaciones beneficiosas eran 24.357.397 acciones indirectas por parte de Family Partnership, 82.301.434 acciones directas y 21.000 acciones indirectas por un IRA de Gregory Lucier.

El 14/10/2025, la persona que reporta realizó un regalo (Código G) de 17.200 opciones sobre acciones no calificadas con un precio de ejercicio de 12,96 $ a una Family Partnership. Estas opciones son ejercitables a partir del 08/08/2026 y vencen el 08/08/2035. La presentación señala el regalo e incluye una renuncia estándar de la titularidad beneficiosa, salvo en lo que respecta al interés pecuniario.

DENTSPLY SIRONA (XRAY): 이사에 의한 포지션 4 안건 거래. 2025년 10월 10일, 제한 주식 단위에 적립된 가족 파트너십으로 배당금으로 0달러에 일반 주식 31만 397주를 취득했습니다. 이로써 유익한 보유 지분은 Family Partnership를 통해 간접적으로 24,357,397주, 직접 보유 82,301,434주, Gregory Lucier IRA를 통한 간접 보유 21,000주가 되었습니다.

2025년 10월 14일, 보고자(공시인)는 가족 파트너십에 12.96달러 행사가로 17,200주의 비자격 주식옵션을 선물로 전달했습니다. 이 옵션은 2026년 8월 8일에 행사 가능하고 2035년 8월 8일에 만료됩니다. 제출 문서에는 선물이 기재되며, 재산 소유권의 표준 면책 조항이 포함되어 있습니다.

DENTSPLY SIRONA (XRAY) : Transaction interne de niveau 4 par un administrateur. Le 10/10/2025, 310 397 actions ordinaires ont été acquises à 0$ sous forme de dividendes sur des unités d’actions restreintes créditées à un Family Partnership. Suite à cela, les participations bénéficiaires étaient de 24 357 397 actions indirectes par Family Partnership, 82 301 434 actions directes et 21 000 actions indirectes par un IRA de Gregory Lucier.

Le 14/10/2025, la personne qui déclare a procédé à un don (Code G) de 17 200 options d’achat d’actions non qualifiées avec un prix d’exercice de 12,96 $ à un Family Partnership. Ces options peuvent être exercées à partir du 08/08/2026 et expirent le 08/08/2035. Le dossier mentionne le don et inclut une clause de non‑possession bénéficiaire standard, sauf en ce qui concerne l’intérêt pécuniaire.

DENTSPLY SIRONA (XRAY): Form 4 Insider-Transaktion durch einen Direktor. Am 10.10.2025 wurden 310.397 Stammaktien zu 0 $ als Dividenden auf Restricted Stock Units, die einem Family Partnership gutgeschrieben wurden, erworben. Danach beliefen sich die berechtigten Anteile indirect durch Family Partnership auf 24.357.397 Aktien, direkt auf 82.301.434 Aktien und indirect durch ein Gregory Lucier IRA auf 21.000 Aktien.

Am 14.10.2025 tätigte die berichtende Person eine Schenkung (Code G) von 17.200 nicht qualifizierten Aktienoptionen mit einem Ausübungspreis von 12,96 $ an ein Family Partnership. Diese Optionen können ab dem 08.08.2026 ausgeübt werden und laufen am 08.08.2035 ab. Die Einreichung vermerkt die Schenkung und enthält einen Standard-Hinweis auf das wirtschaftliche Eigentum, außer im Hinblick auf das wirtschaftliche Interesse.

DENTSPLY SIRONA (XRAY): إجراء داخلي من النوع 4 بواسطة مدير. في 10/10/2025، تم شراء 310,397 سهم من الأسهم العادية بقيمة 0 دولار كأرباح مقسمة على وحدات أسهم مقيدة مُعتمدة لشراكة عائلية. عقب ذلك، كانت الملكيات المستفيدة 24,357,397 سهمًا غير مباشرة عن طريق الشراكة العائلية، و82,301,434 سهمًا مباشرة، و21,000 سهم غير مباشر من IRA الخاص بغريغوري لوسير.

في 14/10/2025، قام الشخص المبلغ عنهم بإهداء (الرمز G) 17,200 خيار أسهم غير مؤهلة بسعر تمرين 12.96 دولارًا إلى شراكة عائلية. هذه الخيارات قابلة للتمرين بدءًا من 08/08/2026 وتنتهي في 08/08/2035. تشير الوثيقة إلى الإهداء وتحتوي على استثناء قياسي لملكية المستفيد باستثناء المصالح المالية.

DENTSPLY SIRONA (XRAY): 董事的 Form 4 内幕交易。 在 2025-10-10,作为分配给一家家族合伙企业的受限股票单位的股息,购买了 310,397 股普通股,价格为 0 美元。随后,受益持股为家族合伙企业间接持有 24,357,397 股,直接持有 82,301,434 股,以及 Gregory Lucier IRA 间接持有 21,000 股。

在 2025-10-14,报告人对一家家族合伙企业以 12.96 美元的行权价赠予 17,200 股非合格股票期权(代码 G)。这些期权可在 2026-08-08 起行使, 并于 2035-08-08 到期。申报文件记载了赠予,并包含关于受益所有权的标准免责声明,除非涉及金钱利益。

Positive
  • None.
Negative
  • None.

DENTSPLY SIRONA (XRAY): Transazione interna di livello 4 da parte di un direttore. Il 10/10/2025 sono state acquisite 310.397 azioni ordinarie a 0$ come dividendi su unità azionarie limitate accreditate a una Family Partnership. A seguito di ciò, le partecipazioni benefici erano 24.357.397 azioni indirette tramite Family Partnership, 82.301.434 azioni dirette e 21.000 azioni indirette da un Individual Retirement Account di Gregory Lucier.

Il 14/10/2025, la persona riferente ha effettuato un dono (Codice G) di 17.200 stock options non qualificate con un prezzo di esercizio di 12,96$ a una Family Partnership. Queste opzioni possono essere esercitate dall'08/08/2026 e scadono l'08/08/2035. La comunicazione riporta il dono e include una normale esclusione della proprietà beneficiaria salvo l'interesse pecuniario.

DENTSPLY SIRONA (XRAY): Transacción de nivel 4 por parte de un director. El 10/10/2025, se adquirieron 310.397 acciones comunes a $0 como dividendos en unidades de acciones restringidas acreditadas a una Family Partnership. Tras esto, las participaciones beneficiosas eran 24.357.397 acciones indirectas por parte de Family Partnership, 82.301.434 acciones directas y 21.000 acciones indirectas por un IRA de Gregory Lucier.

El 14/10/2025, la persona que reporta realizó un regalo (Código G) de 17.200 opciones sobre acciones no calificadas con un precio de ejercicio de 12,96 $ a una Family Partnership. Estas opciones son ejercitables a partir del 08/08/2026 y vencen el 08/08/2035. La presentación señala el regalo e incluye una renuncia estándar de la titularidad beneficiosa, salvo en lo que respecta al interés pecuniario.

DENTSPLY SIRONA (XRAY): 이사에 의한 포지션 4 안건 거래. 2025년 10월 10일, 제한 주식 단위에 적립된 가족 파트너십으로 배당금으로 0달러에 일반 주식 31만 397주를 취득했습니다. 이로써 유익한 보유 지분은 Family Partnership를 통해 간접적으로 24,357,397주, 직접 보유 82,301,434주, Gregory Lucier IRA를 통한 간접 보유 21,000주가 되었습니다.

2025년 10월 14일, 보고자(공시인)는 가족 파트너십에 12.96달러 행사가로 17,200주의 비자격 주식옵션을 선물로 전달했습니다. 이 옵션은 2026년 8월 8일에 행사 가능하고 2035년 8월 8일에 만료됩니다. 제출 문서에는 선물이 기재되며, 재산 소유권의 표준 면책 조항이 포함되어 있습니다.

DENTSPLY SIRONA (XRAY) : Transaction interne de niveau 4 par un administrateur. Le 10/10/2025, 310 397 actions ordinaires ont été acquises à 0$ sous forme de dividendes sur des unités d’actions restreintes créditées à un Family Partnership. Suite à cela, les participations bénéficiaires étaient de 24 357 397 actions indirectes par Family Partnership, 82 301 434 actions directes et 21 000 actions indirectes par un IRA de Gregory Lucier.

Le 14/10/2025, la personne qui déclare a procédé à un don (Code G) de 17 200 options d’achat d’actions non qualifiées avec un prix d’exercice de 12,96 $ à un Family Partnership. Ces options peuvent être exercées à partir du 08/08/2026 et expirent le 08/08/2035. Le dossier mentionne le don et inclut une clause de non‑possession bénéficiaire standard, sauf en ce qui concerne l’intérêt pécuniaire.

DENTSPLY SIRONA (XRAY): Form 4 Insider-Transaktion durch einen Direktor. Am 10.10.2025 wurden 310.397 Stammaktien zu 0 $ als Dividenden auf Restricted Stock Units, die einem Family Partnership gutgeschrieben wurden, erworben. Danach beliefen sich die berechtigten Anteile indirect durch Family Partnership auf 24.357.397 Aktien, direkt auf 82.301.434 Aktien und indirect durch ein Gregory Lucier IRA auf 21.000 Aktien.

Am 14.10.2025 tätigte die berichtende Person eine Schenkung (Code G) von 17.200 nicht qualifizierten Aktienoptionen mit einem Ausübungspreis von 12,96 $ an ein Family Partnership. Diese Optionen können ab dem 08.08.2026 ausgeübt werden und laufen am 08.08.2035 ab. Die Einreichung vermerkt die Schenkung und enthält einen Standard-Hinweis auf das wirtschaftliche Eigentum, außer im Hinblick auf das wirtschaftliche Interesse.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
LUCIER GREGORY T

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28277

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 A 310.397(1) A $0 24,357.397 I By Family Partnership
Common Stock 82,301.434 D
Common Stock 21,000 I by Gregory Lucier IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $12.96 10/14/2025 G 17,200 08/08/2026(2) 08/08/2035 Common Stock 17,200(3) $0 0 D
Stock Option (Right to Buy) $12.96 10/14/2025 G 17,200 08/08/2026(2) 08/08/2035 Common Stock 17,200(3) $0 17,200 I By Family Partnerhip
Explanation of Responses:
1. Represents dividends on restricted stock units (RSUs) awarded to the Family Partnership in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
2. Stock Options vest in full one (1) year from date of grant.
3. Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. The reporting person disclaims beneficial ownership of these NQSOs except to the extent of his pecuniary interest therein, and the inclusion of these NQSOs in this report shall not be an admission that the reporting person is the beneficial owner of the NQSOs for purposes of Section 16 of the Exchange Act or for any other purpose.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did XRAY’s director report on Form 4?

An acquisition of 310.397 common shares as RSU dividends on 10/10/2025 and a gift of 17,200 stock options on 10/14/2025.

How many XRAY shares were held after the RSU dividend?

24,357.397 shares indirect by a Family Partnership, 82,301.434 shares direct, and 21,000 shares indirect by a Gregory Lucier IRA.

What are the terms of the gifted options reported for XRAY?

17,200 non-qualified stock options with a $12.96 exercise price, exercisable 08/08/2026 and expiring 08/08/2035.

What transaction code was used for the option transfer?

Code G, indicating a gift.

Were there any costs reported for the RSU dividend or option gift?

The RSU dividend and the option gift were each reported at a price of $0.

How do the RSU dividends work in this filing?

Dividends on RSUs were credited as additional RSUs that vest on the same schedule, converting to common stock on a 1:1 basis.
Dentsply Sirona Inc

NASDAQ:XRAY

XRAY Rankings

XRAY Latest News

XRAY Latest SEC Filings

XRAY Stock Data

2.52B
198.69M
0.39%
104.2%
3.83%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE